Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 378 entries
Sorted by: Best Match Show Resources per page
Emergency treatment of headache.

Neurology

Rapoport AM, Silberstein SD.
PMID: 1557191
Neurology. 1992 Mar;42(3):43-4.

The first approach in the emergency treatment of headache is the use of abortive measures in an attempt to forestall progression of early signs and symptoms. Abortive measures include analgesics, antiemetics, and anxiolytics; nonsteroidal anti-inflammatory drugs; ergots, generally preceded...

Cite
Rapoport AM, Silberstein SD. Emergency treatment of headache. Neurology. 1992;42(3):43-4
Rapoport, A. M., & Silberstein, S. D. (1992). Emergency treatment of headache. Neurology, 42(3), 43-4.
Rapoport, A M, and Silberstein, S D. "Emergency treatment of headache." Neurology vol. 42,3 (1992): 43-4.
Rapoport AM, Silberstein SD. Emergency treatment of headache. Neurology. 1992 Mar;42(3):43-4. PMID: 1557191.
Copy Download .nbib Format: NLM
NEPA, a new fixed combination of netupitant and palonosetron, is a cost-effective intervention for the prevention of chemotherapy-induced nausea and vomiting in the UK.

Drugs in context

Cawston H, Bourhis F, Eriksson J, Ruffo P, D'Agostino P, Turini M, Schwartzberg L, McGuire A.
PMID: 28392826
Drugs Context. 2017 Mar 24;6:212298. doi: 10.7573/dic.212298. eCollection 2017.

BACKGROUND: The objective was to evaluate the cost-effectiveness of NEPA, an oral fixed combination netupitant (NETU, 300 mg) and palonosetron (PA, 0.5 mg) compared with aprepitant and palonosetron (APPA) or palonosetron (PA) alone, to prevent chemotherapy-induced nausea and vomiting...

Cite
Cawston H, Bourhis F, Eriksson J, et al. NEPA, a new fixed combination of netupitant and palonosetron, is a cost-effective intervention for the prevention of chemotherapy-induced nausea and vomiting in the UK. Drugs Context. 2017;6:212298doi: 10.7573/dic.212298.
Cawston, H., Bourhis, F., Eriksson, J., Ruffo, P., D'Agostino, P., Turini, M., Schwartzberg, L., & McGuire, A. (2017). NEPA, a new fixed combination of netupitant and palonosetron, is a cost-effective intervention for the prevention of chemotherapy-induced nausea and vomiting in the UK. Drugs in context, 6212298. https://doi.org/10.7573/dic.212298
Cawston, Helene, et al. "NEPA, a new fixed combination of netupitant and palonosetron, is a cost-effective intervention for the prevention of chemotherapy-induced nausea and vomiting in the UK." Drugs in context vol. 6 (2017): 212298. doi: https://doi.org/10.7573/dic.212298
Cawston H, Bourhis F, Eriksson J, Ruffo P, D'Agostino P, Turini M, Schwartzberg L, McGuire A. NEPA, a new fixed combination of netupitant and palonosetron, is a cost-effective intervention for the prevention of chemotherapy-induced nausea and vomiting in the UK. Drugs Context. 2017 Mar 24;6:212298. doi: 10.7573/dic.212298. eCollection 2017. PMID: 28392826; PMCID: PMC5378057.
Copy Download .nbib Format: NLM
Phenothiazine vs 5HT3 antagonist prophylactic regimens to prevent Post-Anesthesia Care Unit rescue antiemetic: an observational study.

Open Journal of Anesthesiology

Ruiz JR, Ensor JE, Lim JW, Van Meter A, Rahlfs TF.
PMID: 26635998
Open J Anesthesiol. 2015 Feb;5(2):27-32. doi: 10.4236/ojanes.2015.52006.

PURPOSE: Our practitioners are asked to consider a patient's postoperative nausea and vomiting (PONV) risk profile when developing their prophylactic antiemetic strategy. There is wide variation in employed strategies, and we have yet to determine the most effective PONV...

Cite
Ruiz JR, Ensor JE, Lim JW, et al. Phenothiazine vs 5HT3 antagonist prophylactic regimens to prevent Post-Anesthesia Care Unit rescue antiemetic: an observational study. Open J Anesthesiol. 2015;5(2):27-32doi: 10.4236/ojanes.2015.52006.
Ruiz, J. R., Ensor, J. E., Lim, J. W., Van Meter, A., & Rahlfs, T. F. (2015). Phenothiazine vs 5HT3 antagonist prophylactic regimens to prevent Post-Anesthesia Care Unit rescue antiemetic: an observational study. Open Journal of Anesthesiology, 5(2), 27-32. https://doi.org/10.4236/ojanes.2015.52006
Ruiz, Joseph R, et al. "Phenothiazine vs 5HT3 antagonist prophylactic regimens to prevent Post-Anesthesia Care Unit rescue antiemetic: an observational study." Open Journal of Anesthesiology vol. 5,2 (2015): 27-32. doi: https://doi.org/10.4236/ojanes.2015.52006
Ruiz JR, Ensor JE, Lim JW, Van Meter A, Rahlfs TF. Phenothiazine vs 5HT3 antagonist prophylactic regimens to prevent Post-Anesthesia Care Unit rescue antiemetic: an observational study. Open J Anesthesiol. 2015 Feb;5(2):27-32. doi: 10.4236/ojanes.2015.52006. PMID: 26635998; PMCID: PMC4664192.
Copy Download .nbib Format: NLM
New therapies for antiemetic prophylaxis for chemotherapy.

The Journal of community and supportive oncology

Davis MP.
PMID: 26870838
J Community Support Oncol. 2016 Jan;14(1):11-20. doi: 10.12788/jcso.0206.

A number of new advances have occurred over the past 2 years in the management of chemotherapy-related nausea and vomiting (CINV). A new neurokinin-1 receptor antagonist (NK1RA), netupitant, has been combined with palonosetron in a single oral tablet for...

Cite
Davis MP. New therapies for antiemetic prophylaxis for chemotherapy. J Community Support Oncol. 2016;14(1):11-20doi: 10.12788/jcso.0206.
Davis, M. P. (2016). New therapies for antiemetic prophylaxis for chemotherapy. The Journal of community and supportive oncology, 14(1), 11-20. https://doi.org/10.12788/jcso.0206
Davis, Mellar P. "New therapies for antiemetic prophylaxis for chemotherapy." The Journal of community and supportive oncology vol. 14,1 (2016): 11-20. doi: https://doi.org/10.12788/jcso.0206
Davis MP. New therapies for antiemetic prophylaxis for chemotherapy. J Community Support Oncol. 2016 Jan;14(1):11-20. doi: 10.12788/jcso.0206. PMID: 26870838.
Copy Download .nbib Format: NLM
Postoperative nausea and vomiting after thyroidectomy: a comparison between dexmedetomidine and remifentanil as part of balanced anesthesia.

Korean journal of anesthesiology

Choi EK, Seo Y, Lim DG, Park S.
PMID: 28580080
Korean J Anesthesiol. 2017 Jun;70(3):299-304. doi: 10.4097/kjae.2017.70.3.299. Epub 2017 Mar 15.

BACKGROUND: Postoperative nausea and vomiting (PONV) is the major complication related to general anesthesia, occurring in 60-80% of patients after thyroidectomy. The objective of this study was to compare the effects of an intraoperative dexmedetomidine infusion with remifentanil, as...

Cite
Choi EK, Seo Y, Lim DG, et al. Postoperative nausea and vomiting after thyroidectomy: a comparison between dexmedetomidine and remifentanil as part of balanced anesthesia. Korean J Anesthesiol. 2017;70(3):299-304doi: 10.4097/kjae.2017.70.3.299.
Choi, E. K., Seo, Y., Lim, D. G., & Park, S. (2017). Postoperative nausea and vomiting after thyroidectomy: a comparison between dexmedetomidine and remifentanil as part of balanced anesthesia. Korean journal of anesthesiology, 70(3), 299-304. https://doi.org/10.4097/kjae.2017.70.3.299
Choi, Eun Kyung, et al. "Postoperative nausea and vomiting after thyroidectomy: a comparison between dexmedetomidine and remifentanil as part of balanced anesthesia." Korean journal of anesthesiology vol. 70,3 (2017): 299-304. doi: https://doi.org/10.4097/kjae.2017.70.3.299
Choi EK, Seo Y, Lim DG, Park S. Postoperative nausea and vomiting after thyroidectomy: a comparison between dexmedetomidine and remifentanil as part of balanced anesthesia. Korean J Anesthesiol. 2017 Jun;70(3):299-304. doi: 10.4097/kjae.2017.70.3.299. Epub 2017 Mar 15. PMID: 28580080; PMCID: PMC5453891.
Copy Download .nbib Format: NLM
Paroxetine-induced galactorrhea.

Indian journal of psychiatry

Gulati P, Chavan BS, Das S.
PMID: 25568484
Indian J Psychiatry. 2014 Oct;56(4):393-4. doi: 10.4103/0019-5545.146529.

Drug-induced galactorrhea has been reported with agents such as antidopaminergic antiemetics, antipsychotics, etc., with few case reports of galactorrhea with selective serotonin reuptake inhibitors, including paroxetine, being reported in last few decades. Prolactin levels have been found to be...

Cite
Gulati P, Chavan BS, Das S. Paroxetine-induced galactorrhea. Indian J Psychiatry. 2014;56(4):393-4doi: 10.4103/0019-5545.146529.
Gulati, P., Chavan, B. S., & Das, S. (2014). Paroxetine-induced galactorrhea. Indian journal of psychiatry, 56(4), 393-4. https://doi.org/10.4103/0019-5545.146529
Gulati, Prannay, et al. "Paroxetine-induced galactorrhea." Indian journal of psychiatry vol. 56,4 (2014): 393-4. doi: https://doi.org/10.4103/0019-5545.146529
Gulati P, Chavan BS, Das S. Paroxetine-induced galactorrhea. Indian J Psychiatry. 2014 Oct;56(4):393-4. doi: 10.4103/0019-5545.146529. PMID: 25568484; PMCID: PMC4279301.
Copy Download .nbib Format: NLM
A comparative study of effects of glycopyrrolate and ondansetron on nausea and vomiting in cesarean section under spinal anesthesia.

Anesthesia, essays and researches

Jain R, Sharma R.
PMID: 26712972
Anesth Essays Res. 2015 Sep-Dec;9(3):348-52. doi: 10.4103/0259-1162.159725.

BACKGROUND AND AIM: Nausea and vomiting causes distress to patients and increases surgical complications. Though various antiemetics are available, their effectiveness and fetal safety profile when used in parturient remains debatable. This randomized, double-blind, comparative study was designed with...

Cite
Jain R, Sharma R. A comparative study of effects of glycopyrrolate and ondansetron on nausea and vomiting in cesarean section under spinal anesthesia. Anesth Essays Res. 2015;9(3):348-52doi: 10.4103/0259-1162.159725.
Jain, R., & Sharma, R. (2015). A comparative study of effects of glycopyrrolate and ondansetron on nausea and vomiting in cesarean section under spinal anesthesia. Anesthesia, essays and researches, 9(3), 348-52. https://doi.org/10.4103/0259-1162.159725
Jain, Ragi, and Sharma, Rashmi. "A comparative study of effects of glycopyrrolate and ondansetron on nausea and vomiting in cesarean section under spinal anesthesia." Anesthesia, essays and researches vol. 9,3 (2015): 348-52. doi: https://doi.org/10.4103/0259-1162.159725
Jain R, Sharma R. A comparative study of effects of glycopyrrolate and ondansetron on nausea and vomiting in cesarean section under spinal anesthesia. Anesth Essays Res. 2015 Sep-Dec;9(3):348-52. doi: 10.4103/0259-1162.159725. PMID: 26712972; PMCID: PMC4683504.
Copy Download .nbib Format: NLM
A Comparative Evaluation of Ramosetron with Ondansetron for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Urological Procedures.

Anesthesia, essays and researches

Mujoo S, Ali Z, Jehangir M, Iqbal A, Qayoom N, Lone AQ.
PMID: 28298761
Anesth Essays Res. 2017 Jan-Mar;11(1):78-83. doi: 10.4103/0259-1162.200244.

BACKGROUND: Postoperative nausea and vomiting (PONV) is a common problem causing distress to patients in the postoperative period. Younger age, gynecological surgeries, laparoscopic surgeries, female gender, volatile anesthetics, increased duration of anesthesia, and postoperative opioid use are associated with...

Cite
Mujoo S, Ali Z, Jehangir M, et al. A Comparative Evaluation of Ramosetron with Ondansetron for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Urological Procedures. Anesth Essays Res. 2017;11(1):78-83doi: 10.4103/0259-1162.200244.
Mujoo, S., Ali, Z., Jehangir, M., Iqbal, A., Qayoom, N., & Lone, A. Q. (2017). A Comparative Evaluation of Ramosetron with Ondansetron for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Urological Procedures. Anesthesia, essays and researches, 11(1), 78-83. https://doi.org/10.4103/0259-1162.200244
Mujoo, Samiullah, et al. "A Comparative Evaluation of Ramosetron with Ondansetron for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Urological Procedures." Anesthesia, essays and researches vol. 11,1 (2017): 78-83. doi: https://doi.org/10.4103/0259-1162.200244
Mujoo S, Ali Z, Jehangir M, Iqbal A, Qayoom N, Lone AQ. A Comparative Evaluation of Ramosetron with Ondansetron for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Urological Procedures. Anesth Essays Res. 2017 Jan-Mar;11(1):78-83. doi: 10.4103/0259-1162.200244. PMID: 28298761; PMCID: PMC5341670.
Copy Download .nbib Format: NLM
Differential pharmacology and clinical utility of rolapitant in chemotherapy-induced nausea and vomiting.

Cancer management and research

Rapoport BL.
PMID: 28260945
Cancer Manag Res. 2017 Feb 22;9:41-50. doi: 10.2147/CMAR.S97543. eCollection 2017.

Chemotherapy-induced nausea and vomiting (CINV) is a debilitating side effect of many cytotoxic chemotherapy regimens. CINV typically manifests during two well-defined time periods (acute and delayed phases). The acute phase is the first 24 hours after chemotherapy and is...

Cite
Rapoport BL. Differential pharmacology and clinical utility of rolapitant in chemotherapy-induced nausea and vomiting. Cancer Manag Res. 2017;9:41-50doi: 10.2147/CMAR.S97543.
Rapoport, B. L. (2017). Differential pharmacology and clinical utility of rolapitant in chemotherapy-induced nausea and vomiting. Cancer management and research, 941-50. https://doi.org/10.2147/CMAR.S97543
Rapoport, Bernardo Leon. "Differential pharmacology and clinical utility of rolapitant in chemotherapy-induced nausea and vomiting." Cancer management and research vol. 9 (2017): 41-50. doi: https://doi.org/10.2147/CMAR.S97543
Rapoport BL. Differential pharmacology and clinical utility of rolapitant in chemotherapy-induced nausea and vomiting. Cancer Manag Res. 2017 Feb 22;9:41-50. doi: 10.2147/CMAR.S97543. eCollection 2017. PMID: 28260945; PMCID: PMC5327850.
Copy Download .nbib Format: NLM
Nausea and Vomiting.

Current treatment options in gastroenterology

Fraga XF, Malagelada JR.
PMID: 12095471
Curr Treat Options Gastroenterol. 2002 Aug;5(4):241-250. doi: 10.1007/s11938-002-0046-6.

Nausea and vomiting are rather stereotyped symptoms. The challenge is that nausea and vomiting have many different causes and, in some patients, management may be rather complex. The clue is to determine the causal factor early. It helps to...

Cite
Fraga XF, Malagelada JR. Nausea and Vomiting. Curr Treat Options Gastroenterol. 2002;5(4):241-250doi: 10.1007/s11938-002-0046-6.
Fraga, X. F., & Malagelada, J. R. (2002). Nausea and Vomiting. Current treatment options in gastroenterology, 5(4), 241-250. https://doi.org/10.1007/s11938-002-0046-6
Fraga, Xose Fernández, and Malagelada, Juan R.. "Nausea and Vomiting." Current treatment options in gastroenterology vol. 5,4 (2002): 241-250. doi: https://doi.org/10.1007/s11938-002-0046-6
Fraga XF, Malagelada JR. Nausea and Vomiting. Curr Treat Options Gastroenterol. 2002 Aug;5(4):241-250. doi: 10.1007/s11938-002-0046-6. PMID: 12095471.
Copy Download .nbib Format: NLM
A survey on the management of nausea and vomiting in pregnancy by obstetrician/gynecologists.

Primary care update for Ob/Gyns

Power ML, Holzman GB, Schulkin J.
PMID: 11246031
Prim Care Update Ob Gyns. 2001 Mar;8(2):69-72. doi: 10.1016/s1068-607x(00)00077-9.

Our objective was to survey obstetrician/gynecologists concerning their management of nausea and vomiting in pregnancy. We mailed a survey on nutrition during pregnancy to the 230 ACOG Fellows who are members of the Collaborative Ambulatory Research Network and to...

Cite
Power ML, Holzman GB, Schulkin J. A survey on the management of nausea and vomiting in pregnancy by obstetrician/gynecologists. Prim Care Update Ob Gyns. 2001;8(2):69-72doi: 10.1016/s1068-607x(00)00077-9.
Power, M. L., Holzman, G. B., & Schulkin, J. (2001). A survey on the management of nausea and vomiting in pregnancy by obstetrician/gynecologists. Primary care update for Ob/Gyns, 8(2), 69-72. https://doi.org/10.1016/s1068-607x(00)00077-9
Power, M L., et al. "A survey on the management of nausea and vomiting in pregnancy by obstetrician/gynecologists." Primary care update for Ob/Gyns vol. 8,2 (2001): 69-72. doi: https://doi.org/10.1016/s1068-607x(00)00077-9
Power ML, Holzman GB, Schulkin J. A survey on the management of nausea and vomiting in pregnancy by obstetrician/gynecologists. Prim Care Update Ob Gyns. 2001 Mar;8(2):69-72. doi: 10.1016/s1068-607x(00)00077-9. PMID: 11246031.
Copy Download .nbib Format: NLM
Combination therapy for postoperative nausea and vomiting - a more effective prophylaxis?.

Ambulatory surgery

Habib AS, Gan TJ.
PMID: 11454483
Ambul Surg. 2001 Jul;9(2):59-71. doi: 10.1016/s0966-6532(01)00103-2.

The problem of postoperative nausea and vomiting (PONV) remains far from being resolved. Despite the introduction of new classes of antiemetics and a vast amount of published research, there is a general impression that there has been little progress...

Cite
Habib AS, Gan TJ. Combination therapy for postoperative nausea and vomiting - a more effective prophylaxis?. Ambul Surg. 2001;9(2):59-71doi: 10.1016/s0966-6532(01)00103-2.
Habib, A. S., & Gan, T. J. (2001). Combination therapy for postoperative nausea and vomiting - a more effective prophylaxis?. Ambulatory surgery, 9(2), 59-71. https://doi.org/10.1016/s0966-6532(01)00103-2
Habib, A S., and Gan, T J.. "Combination therapy for postoperative nausea and vomiting - a more effective prophylaxis?." Ambulatory surgery vol. 9,2 (2001): 59-71. doi: https://doi.org/10.1016/s0966-6532(01)00103-2
Habib AS, Gan TJ. Combination therapy for postoperative nausea and vomiting - a more effective prophylaxis?. Ambul Surg. 2001 Jul;9(2):59-71. doi: 10.1016/s0966-6532(01)00103-2. PMID: 11454483.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 378 entries